Shobha Ravipaty, PhD

Director at Stoke Therapeutics

Speaker

Shobha Ravipaty is a Director in the Translational DMPK & Clinical Pharmacology group at Stoke Therapeutics where she supports late discovery, pre-clinical and clinical development programs.

Prior to joining Stoke in 2019, Shobha worked at BPGbio (formerly Berg) where she led a team of scientists responsible for developing, qualifying/validating and implementing LC-MS or immunoassay based bioanalytical methods for quantitation of small molecule/protein therapeutics and biomarkers in a regulated environment (CLIA) to support non-clinical, clinical and diagnostic programs. Shobha started her career in the industry as a Scientist at Celerion focusing on regulated (GLP) bioanalysis. Shobha earned her PhD degree in Analytical Chemistry from Michigan Technological University and received postdoctoral training in mass spectrometry-based proteomics at Indiana University.